MetLife, Inc. (MET)
- Previous Close
81.09 - Open
81.00 - Bid 80.80 x 800
- Ask 80.81 x 900
- Day's Range
80.55 - 81.04 - 52 Week Range
57.91 - 81.39 - Volume
8,962,158 - Avg. Volume
3,334,888 - Market Cap (intraday)
56.621B - Beta (5Y Monthly) 1.03
- PE Ratio (TTM)
21.97 - EPS (TTM)
3.68 - Earnings Date Oct 30, 2024 - Nov 4, 2024
- Forward Dividend & Yield 2.18 (2.70%)
- Ex-Dividend Date Aug 6, 2024
- 1y Target Est
86.28
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.
www.metlife.com45,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MET
View MoreResearch Reports: MET
View MorePerformance Overview: MET
Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MET
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MET
View MoreValuation Measures
Market Cap
56.62B
Enterprise Value
71.92B
Trailing P/E
21.97
Forward P/E
8.25
PEG Ratio (5yr expected)
0.14
Price/Sales (ttm)
0.87
Price/Book (mrq)
2.08
Enterprise Value/Revenue
1.06
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
4.23%
Return on Assets (ttm)
0.42%
Return on Equity (ttm)
10.12%
Revenue (ttm)
68.77B
Net Income Avi to Common (ttm)
2.71B
Diluted EPS (ttm)
3.68
Balance Sheet and Cash Flow
Total Cash (mrq)
27.73B
Total Debt/Equity (mrq)
174.13%
Levered Free Cash Flow (ttm)
-1.99B